BLT benitec biopharma limited

time for a reality check, page-5

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    In case anyone needed more evidence supporting Max's statement this sobering comment from the Optician about gene therapy for ocular diseases may be of interest. The article says:

    So here we have diseases of the eye, generally regarded as the easiest target for gene therapy, taking two decades to report results. Kinda makes a few weeks delay for TT-034 seem insignificant don't you think?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.